These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 979644)

  • 1. Dominant inheritance of large molecular weight species of glucagon.
    Ensinck JW; Palmer JP
    Metabolism; 1976 Nov; 25(11 Suppl 1):1409-11. PubMed ID: 979644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant inheritance of large molecular weight immunoreactive glucagon.
    Palmer JP; Werner PL; Benson JW; Ensinck JW
    J Clin Invest; 1978 Mar; 61(3):763-9. PubMed ID: 641153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial hyperglucagonemia--an autosomal dominant disorder.
    Boden G; Owen OE
    N Engl J Med; 1977 Mar; 296(10):534-8. PubMed ID: 189188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
    Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
    J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Size heterogeneity of immunoreactive glucagon during bile-duct obstruction in the rabbit.
    Sanke T
    Endocrinol Jpn; 1982 Oct; 29(5):541-51. PubMed ID: 6763562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive circulating large molecular weight immunoreactive glucagon components in subjects with the idiopathic postprandial syndrome.
    Charles MA; Waldeck N
    J Clin Endocrinol Metab; 1981 Aug; 53(2):366-71. PubMed ID: 6265488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma.
    Valverde I; Lemon HM; Kessinger A; Unger RH
    J Clin Endocrinol Metab; 1976 May; 42(5):804-8. PubMed ID: 178682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic characterization of plasma glucagon components in a patient with malignant glucagonoma.
    Tanaka K; Watabe T; Shimizu N; Horiuchi T; Nakamura K; Yoshida H
    Metabolism; 1984 Aug; 33(8):728-33. PubMed ID: 6087085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma glucagon and insulin in rat pregnancy. Roles in glucose homeostasis.
    Saudek CD; Finkowski M; Knopp RH
    J Clin Invest; 1975 Jan; 55(1):180-7. PubMed ID: 1109177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the liver in glucagon metabolism.
    Jaspan JB; Huen AH; Morley CG; Moossa AR; Rubenstein AH
    J Clin Invest; 1977 Aug; 60(2):421-8. PubMed ID: 874100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human.
    Bringer J; Mirouze J; Marchal G; Pham TC; Luyckx A; Lefebvre P; Orsetti A
    Diabetes; 1981 Oct; 30(10):851-6. PubMed ID: 6115786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on persistent circulating immunoreactive glucagon (IRG) and immunoreactive insulin (IRI) found in eviscerated rats with a functional liver.
    Smith SS; Bhathena SJ; Nompleggi D; Penhos JC; Recant L
    Diabetologia; 1978 Mar; 14(3):177-84. PubMed ID: 658634
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels.
    McDonald TJ; Dupre J; Caussignac Y; Radziuk J; Van Vliet S
    Metabolism; 1979 Apr; 28(4):300-7. PubMed ID: 449682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma glucose, insulin, glucagon, and growth hormone in kindreds with maturity-onset type of hyperglycemia in young people.
    Barbosa J; Ramsay R; Goetz FC
    Ann Intern Med; 1978 May; 88(5):595-601. PubMed ID: 646240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential immunoreactivity of plasma glucagon components in man: studies with different glucagon antibodies.
    Soybel D; Jaspan J; Polonsky K; Goldberg I; Rayfield E; Tager H
    J Clin Endocrinol Metab; 1983 Mar; 56(3):612-8. PubMed ID: 6185527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of immunoreactive glucagon in portal, arterial and peripheral plasma before and after removal of glucagonoma.
    Villar HV; Johnson DG; Lynch PJ; Pond GD; Smith PH
    Am J Surg; 1981 Jan; 141(1):148-52. PubMed ID: 6257127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancy of fasting plasma glucagon levels measured by different glucagon antisera.
    Tahara Y; Tanaka A; Yamamoto Y; Fukuda M; Kumahara Y; Shima K
    Diabetes Res; 1988 Apr; 7(4):179-83. PubMed ID: 3402167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated pancreatic glucagon in obesity.
    Starke AA; Erhardt G; Berger M; Zimmermann H
    Diabetes; 1984 Mar; 33(3):277-80. PubMed ID: 6365661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between changes or sugar metabolism and blood insulin and glucagon levels in liver diseases. Part II. On the responses of blood IRI and IRG to oral glucose and intravenous arginine administrations in accordance with glucose tolerance (author's transl)].
    Kikuchi A; Kihara A
    Nihon Shokakibyo Gakkai Zasshi; 1979 Feb; 76(2):212-22. PubMed ID: 439481
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterogeneity of plasma glucagon: patterns in patients with chronic renal failure and diabetes.
    Kuku SF; Zeidler A; Emmanouel DS; Katz AI; Rubenstein AH
    J Clin Endocrinol Metab; 1976 Jan; 42(1):173-6. PubMed ID: 1249185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.